Loading market dashboard
Marinus Pharmaceuticals, Inc.
MRNSHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Marinus Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $104.64M | $104.64M - $104.64M | -$46.03M | $0.385 | 1 |
| Dec 2027 | $82.82M | $82.82M - $82.82M | -$36.44M | $0.176 | 5 |
| Dec 2026 | $61.31M | $61.31M - $61.31M | -$26.97M | -$0.208 | 5 |
| Dec 2025 | $55.41M | $52.36M - $60.99M | -$24.38M | -$0.498 | 6 |
| Dec 2024 | $34.87M | $32.27M - $41.88M | -$15.34M | -$2.065 | 5 |
| Dec 2023 | $30.26M | $30.26M - $30.26M | -$13.31M | -$2.658 | 2 |
| Dec 2022 | $27.71M | $18.67M - $33.92M | -$12.19M | -$0.341 | 5 |
| Dec 2021 | $17.03M | $11.28M - $24.63M | -$7.58M | -$2.682 | 6 |
| Dec 2020 | $1.37M | $904.8K - $1.98M | -$608.1K | -$2.453 | 6 |